You are here: All Products  > BeiGene Starts China Trial of PI-1 Drug in Hodgkin Lymphoma

BeiGene Starts China Trial of PI-1 Drug in Hodgkin Lymphoma

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.